- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06445426
Cystometry Using a Novel Microsensor System in Patients With Neurogenic Bladder Dysfunction (PEPRE2)
June 13, 2024 updated by: Thomas Glott, Sunnaas Rehabilitation Hospital
The aim of this study is to assess the feasibility and safety of a novel system for percutaneous measurement of bladder pressure.
This system enables minimally invasive procedures and high-quality recordings, offering a sampling rate and synchronization surpassing traditional methods.
The pressure sensor system has the potential to be developed into a low-cost method suitable for mass production.
The study will include a sample of convenience of up to 40 subjects.
Pressure will be recorded simultaneously in the bladder using both the conventional and novel pressure recording systems.
This simultaneous recording method will provide a direct comparison of pressure recordings between the two systems.
Subjects will be examined for any subjective or objective adverse events.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The aim of this study is to assess the feasibility and safety of a novel system for measurement of bladder pressure.
The system facilitates a minimally invasive procedure, enabling high-quality recordings with a sampling rate and synchronization that surpass conventional standards.
The pressure sensor system has potential to be developed into a low-cost method with mass production.
In patients with spinal cord injury and neurogenic bladder dysfunction, measurement of pressure in the bladder (cystometry) is mandatory to evaluate risk factors and assess treatment options.
This novel system consists of a micro electro mechanical system (MEMS) integrated in a hollow flexible tube made out of biocompatible material.
Recording from this sensor catheter is transmitted to specialized electronic and digital devices for processing.
Due to a sensor catheter with a diameter less than 1.0 mm, it is possible to perform transurethral cystometry using a simple minimally invasive technique.
The study goal is to compare the simultaneous measurement of the conventional water perfused system compared to a novel pressure sensor system during cystometry.
produce high-quality recordings with a higher than conventional sampling rate.
The study will include a sample of convenience of up to 40 subjects.
The pressure will be recorded simultaneously with the conventional and novel pressure recording system in the urinary bladder.
The simultaneous recording with the novel and the conventional method will provide a direct comparison of simultaneous recording of pressure between the two systems.
Patients will be examined for subjective or objective adverse events.
The sample size is too small for comparison of validity of the two methods in clinical practice.
However, the study should be able to conclude on reliability.
Thus, pressure measurements will be assessed with both methods during cystometry in up to 40 subjects.
Given the technical specifications, the measurements are expected to be nearly identical, thereby ensuring reliability.
The study is not intended to provide conclusive results on the comparison between conventional water perfused recording and the novel MEMS pressure system.
However, results from this initial study will be the basis for further studies with sufficient power to validate conventional versus novel MEMS technique.
Study Type
Observational
Enrollment (Actual)
33
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Nesoddtangen
-
Oslo, Nesoddtangen, Norway, N-1450
- Sunnaas Rehabilitation Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Subjects will be recruited from patients with chronic spinal cord injury (SCI) admitted for cystometry at Sunnaas Hospital´s urodynamic laboratory.
All subjects will have a clinical indication for cystometry.
Description
Inclusion Criteria:
- Documented traumatic or non-traumatic spinal cord injury
- Documented neurogenic bladder dysfunction by previous cystometry
- More than 3 months after injury
- Subject is able to communicate in Norwegian
- Subject is able and willing to sign informed consent
- Subject is able to complete all study requirements
Exclusion Criteria:
- History or evidence of previous urological or lower abdominal abnormalities from disease or surgery
- Use of anti-platelet or anti-coagulant other than low molecular weight heparin or acetylsalicylic acid which cannot be discontinued
- Symptomatic urinary tract infection
- Hemophilia or other clotting disorders that cause bleeding diathesis
- Any condition or situation, which, in the investigator's opinion, puts the subject at significant risk, could confound the study results, or may interfere significantly with the subject's participation in the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Simulataneous bladder pressure recording
In all patients recruited, the pressure will be recorded simultaneously with the conventional and novel pressure recording systems in the bladder.
The procedure will be done according to the International Continence Society's (ICS) recommended indications for the procedure.
|
The procedure will be done according to the International Continence Society's (ICS) recommended indications for the procedure.
The investigational device is inserted into a 12F single-use hydrophilic catheter.
After correct positioning is verified by ultrasound and x-ray, the investigational device is released from the insertion catheter.
The insertion catheter is then carefully removed, securing the correct positioning of the investigational device inside the bladder.
The investigational device is connected to a data logger.
In the conventional device, the intravesical pressure is recorded using a water perfused 3F catheter with a 3 ml/hour perfusion rate.
The 3F catheter is hooked on an 8F catheter to facilitate introduction into the bladder.
The catheters used for pressure transmission are connected to external transducers and a computer with software processing the recording
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Bladder pressure
Time Frame: 24 hours
|
The bladder pressure recorded simultaneously by a conventional clinical system and the prototype will be used for a systemstic comparison analysis in the time-amplitude and the time-frequency domains.
|
24 hours
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Advert effects monitoring and resolution
Time Frame: 72 hours
|
Subjects will be examined for any subjective or objective adverse events.
The transurethral technique is well-known, and the complication rates are very low.
However, there are known complications such as urinary tract infection, hematuria, pain, retention, and autonomic dysreflexia in tetraplegics.
Subjects will be routinely examined for all these conditions, and if any of them occur, adequate treatment will be initiated according to hospital guidelines.
The small-sized sensor tube (Ø ≈ 1.2 mm) provides a minimally invasive clinical procedure.
In case of perforation, the lesion will be small.
|
72 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2022
Primary Completion (Actual)
October 31, 2023
Study Completion (Actual)
December 31, 2023
Study Registration Dates
First Submitted
August 5, 2022
First Submitted That Met QC Criteria
May 31, 2024
First Posted (Actual)
June 6, 2024
Study Record Updates
Last Update Posted (Actual)
June 14, 2024
Last Update Submitted That Met QC Criteria
June 13, 2024
Last Verified
June 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Central Nervous System Diseases
- Nervous System Diseases
- Urologic Diseases
- Urinary Bladder Diseases
- Neurologic Manifestations
- Wounds and Injuries
- Trauma, Nervous System
- Spinal Cord Diseases
- Female Urogenital Diseases
- Female Urogenital Diseases and Pregnancy Complications
- Urogenital Diseases
- Male Urogenital Diseases
- Spinal Cord Injuries
- Urinary Bladder, Neurogenic
Other Study ID Numbers
- SUPRE
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Spinal Cord Injuries
-
Khon Kaen UniversityUnknownInjuries, Spinal Cord
-
Universidade do Vale do ParaíbaCompletedInjuries, Spinal Cord
-
InVivo TherapeuticsTerminated
-
Ekso BionicsBurke Medical Research InstituteCompletedInjuries, Spinal CordUnited States
-
ReWalk Robotics, Inc.Unknown
-
Shepherd Center, Atlanta GACompletedInjuries, Spinal Cord
-
Wroclaw Medical UniversityInstitute of Immunology and Experimental Therapy of the Polish Academy of... and other collaboratorsUnknownComplete Spinal Cord InjuriesPoland
-
Lineage Cell Therapeutics, Inc.CompletedCervical Spinal Cord Injury | Spine Injury | Spinal Cord TraumaUnited States
Clinical Trials on Cystometry
-
Astellas Pharma IncGlaxoSmithKlineCompleted
-
Astellas Pharma IncTerminatedBladder FunctionUnited States
-
Teesside UniversitySouth Tees Hospitals NHS Foundation TrustNot yet recruitingOveractive Bladder | Overactive Bladder Syndrome | Detrusor Overactivity
-
Koç UniversityRecruitingMultiple Sclerosis | Neurogenic BladderTurkey
-
Duke UniversityRecruiting
-
North Bristol NHS TrustUniversity of Sheffield; University of Bristol; Newcastle University; University... and other collaboratorsUnknownLower Urinary Tract Symptoms | Voiding Dysfunction | Detrusor Underactivity | Benign Prostate ObstructionUnited Kingdom
-
University Hospital, GhentRecruitingIncontinence, Urge | Incontinence Stress | Incontinence, Daytime Urinary | Incontinence, Nighttime UrinaryBelgium
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedOveractive BladderSwitzerland
-
The First Affiliated Hospital of Soochow UniversityRecruitingRelapsed/Refractory Peripheral T-cell LymphomaChina
-
Regina Elena Cancer InstituteIcahn School of Medicine at Mount Sinai; University of Roma La SapienzaUnknownMultiple Sclerosis | RelapseUnited States, Italy